Filing Details
- Accession Number:
- 0001181431-13-063423
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-12-18 17:27:14
- Reporting Period:
- 2013-12-16
- Filing Date:
- 2013-12-18
- Accepted Time:
- 2013-12-18 17:27:14
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1070336 | Achillion Pharmaceuticals Inc | ACHN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1290166 | Qvt Associates Gp Llc | 1177 Avenue Of The Americas 9Th Floor New York NY 10036 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.001 Par Value | Disposition | 2013-12-16 | 50,647 | $3.13 | 11,662,306 | No | 4 | S | Indirect | Through QVT Fund IV LP, QVT Fund V LP and Quintessence Fund L.P. |
Common Stock, $0.001 Par Value | Disposition | 2013-12-17 | 42,156 | $3.08 | 11,620,150 | No | 4 | S | Indirect | Through QVT Fund IV LP, QVT Fund V LP and Quintessence Fund L.P. |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | Through QVT Fund IV LP, QVT Fund V LP and Quintessence Fund L.P. |
No | 4 | S | Indirect | Through QVT Fund IV LP, QVT Fund V LP and Quintessence Fund L.P. |